Wells Fargo & Company Taro Pharmaceutical Industries LTD Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Taro Pharmaceutical Industries LTD stock. As of the latest transaction made, Wells Fargo & Company holds 3,578 shares of TARO stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,578
Previous 2,760
29.64%
Holding current value
$0
Previous $115,000
31.3%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding TARO
# of Institutions
85Shares Held
4.58MCall Options Held
7KPut Options Held
6.3K-
Krensavage Asset Management, LLC New York, NY648KShares$012.16% of portfolio
-
Black Rock Inc. New York, NY616KShares$00.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny571KShares$00.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX520KShares$00.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA284KShares$00.16% of portfolio
About TARO PHARMACEUTICAL INDUSTRIES LTD
- Ticker TARO
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 37,584,600
- Description
- Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...